Q2 Earnings Estimate for ImmunityBio Issued By HC Wainwright
ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) – Analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for ImmunityBio in a report released on Monday, May 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings of ($0.09) per share for the quarter, up from their prior estimate of […]
ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) – Analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for ImmunityBio in a report released on Monday, May 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings of ($0.09) per share for the quarter, up from their prior estimate of […]
